Eton Pharmaceuticals, Inc. (ETON) — Gross Profit
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $42.74M | +82.6% |
| 2024 | $23.41M | +11.2% |
| 2023 | $21.06M | +47.1% |
| 2022 | $14.32M | -24.7% |
| 2021 | $19.00M | +4887.2% |
| 2020 | -$397.0K | -178.5% |
| 2019 | $506.0K | — |
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $42.74M | +82.6% |
| 2024 | $23.41M | +11.2% |
| 2023 | $21.06M | +47.1% |
| 2022 | $14.32M | -24.7% |
| 2021 | $19.00M | +4887.2% |
| 2020 | -$397.0K | -178.5% |
| 2019 | $506.0K | — |